Skip to content

Drug interactions

Midazolam + Ustekinumab

Severity: Minor

Midazolam and Ustekinumab: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Chronic inflammation suppresses CYP450 enzyme expression through raised cytokine levels, and IL-12/23 blockade may allow enzyme activity to return toward normal. This could lower exposure to CYP3A4 substrates such as midazolam after ustekinumab is started. The effect is expected to be small and is mostly theoretical.

What this interaction means in plain words

Midazolam and Ustekinumab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Midazolam belongs to Central Nervous System; Ustekinumab belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Cytokine modulation by IL-12/23 inhibition may normalize cytokine-suppressed CYP3A4 expression and increase midazolam clearance.

What to do

No routine dose change is needed; observe sedative response when ustekinumab is started or stopped in patients with active inflammatory disease.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Midazolam and Ustekinumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Midazolam with Ustekinumab?

MediHelp rates the interaction as minor. Midazolam and Ustekinumab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Chronic inflammation suppresses CYP450 enzyme expression through raised cytokine levels, and IL-12/23 blockade may allow enzyme activity to return toward normal. This could lower exposure to CYP3A4 substrates such as midazolam after ustekinumab is started. The effect is expected to be small and is mostly theoretical.

How serious is the interaction between Midazolam and Ustekinumab?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed; observe sedative response when ustekinumab is started or stopped in patients with active inflammatory disease.

What other medicines interact with Ustekinumab?

MediHelp also lists interactions of Ustekinumab with, for example, Bcg vaccine live, Typhoid vaccine live, Adalimumab. The full list is on the Ustekinumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in